Avadel Pharmaceuticals PLC (AD - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
AVDL Nasdaq 2834 https://www.avadel.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Avadel Pharmaceuticals PLC (AD

The medical condition 72 percent of Americans don’t know about is stealing sleep and disrupting lives, survey shows - Sep 12th, 2018 6:30 am
Brandes Investments Expands Stake in Avadel Pharmaceuticals - Sep 6th, 2018 3:54 pm
Avadel Pharmaceuticals to Present at the 2018 Wells Fargo Healthcare Conference - Aug 30th, 2018 5:30 am
New Data on NOCTIVA™ Presented at the 2018 International Continence Society Meeting - Aug 29th, 2018 6:35 am
Analysis: Positioning to Benefit within Armstrong Flooring, U.S. Global Investors, Aqua Metals, Clearside Biomedical, EP Energy, and Avadel Pharmaceuticals — Research Highlights Growth, Revenue, and Consolidated Results - Aug 17th, 2018 6:15 am
Avadel Pharmaceuticals PLC Sponsored ADR to Host Earnings Call - Aug 7th, 2018 6:00 am
Avadel: 2Q Earnings Snapshot - Aug 7th, 2018 5:42 am
Avadel Pharmaceuticals Reports Second Quarter 2018 Financial Results - Aug 7th, 2018 5:30 am
Breakfast Technical Briefing on Avid Bioservices and Three Other Additional Biotech Stocks - Jul 19th, 2018 5:45 am
Avadel Pharmaceuticals to Report Second Quarter 2018 Results - Jul 17th, 2018 5:33 am
Should You Expect Avadel Pharmaceuticals plc (NASDAQ:AVDL) To Continue Delivering An ROE Of 34.61%? - Jun 27th, 2018 10:37 am
Free Technical Insights on CASI Pharma and Three Other Biotech Stocks - May 31st, 2018 6:30 am